Jul 30, 2020 / 08:00AM GMT
Operator
Ladies and gentlemen, welcome to the Cosmo Pharmaceuticals Half Year Results 2020 Conference Call. I am Alice, the Chorus Call operator. The conference must not be recorded for publication or broadcast.
At this time, it's my pleasure to hand over to the management team of Cosmo Pharmaceuticals. Please go ahead, gentlemen.
Alessandro E. Della Chà - Cosmo Pharmaceuticals N.V. - CEO & Executive Director
Good morning, everyone. This is Alessandro Della Chà . Thanks for joining our call. And let me walk you through the introduction and the first half 2020 key events.
As you might have seen from the press releases that we have released in the past days, we're very pleased to report a series of very good and positive developments that have happened to date. And first of all, let us confirm that we are on track to return to operating profit for the financial year 2020, as already announced, as a result of the actions that we have taken in the last 18 months.
So to begin with the good news. The first one was the EMA's CHMP has adopted a
Half Year 2020 Cosmo Pharmaceuticals NV Earnings Call Transcript
Feb 13, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers